BD PHOENIX¿ NID
Report
- Report Number
- 1119779-2024-00006
- Event Type
- Malfunction
- Date Received
- January 5, 2024
- Date of Event
- October 28, 2023
- Report Date
- April 11, 2024
- Manufacturer
- BECTON, DICKINSON & CO. (SPARKS)
- Product Code
- LQM
- UDI-DI
- 30382904480074
- PMA / PMN Number
- SEE H10
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE FOLLOWING INFORMATION HAS BEEN UPDATED WITH CORRECTED AND/OR ADDITIONAL INFORMATION: D9: DEVICE AVAILABLE FOR EVAL? YES. D9: RETURNED TO MANUFACTURER ON: 10-NOV-2023. H6: INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR FALSE POSITIVE ESBL RESULTS WITH KLEBSIELLA OXYTOCA WHEN USING PHOENIX PANEL NMIC-311 (CATALOG NUMBER 449452) BATCH NUMBERS 3241410 AND 3202514. THE CUSTOMER DID NOT PROVIDE ISOLATE RETURNS BUT PROVIDED PANEL RETURNS AND PHOENIX GENERATED LAB REPORTS FOR THE INVESTIGATION. THE LAB REPORTS SHOW POSITIVE ESBL RESULTS FOR K. OXYTOCA FROM A URINE AND SPUTUM SAMPLE WHEN USING THE COMPLAINT BATCH. IT IS TO BE NOTED THAT BATCH 3202514 IS AN ID ONLY PANEL AND THEREFORE DOES NOT TEST FOR ESBL RESULTS AND WAS NOT USED IN INVESTIGATION TESTING. TO INVESTIGATE, THREE CUSTOMER RETURNED PANELS EACH FROM COMPLAINT BATCH 3241410 WERE INOCULATED WITH IN HOUSE ISOLATES K. OXYTOCA 18410 AND K. OXYTOCA 18411 AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL RESULTS. ADDITIONALLY, ONE CONTROL PANEL EACH FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE INOCULATED WITH IN HOUSE ISOLATES K. OXYTOCA 18410 AND K. OXYTOCA 18411 AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL RESULTS. DURING THE INVESTIGATION TESTING, THE EIGHT PANELS TESTED DID NOT RETURN ESBL POSITIVE RESULTS, THEREFORE, THIS COMPLAINT IS NOT CONFIRMED. THE BATCH HISTORY RECORDS WERE SATISFACTORY, AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED, AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. A REVIEW OF COMPLAINTS REVEALED NO OTHER COMPLAINTS ON THIS BATCH. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY.
G.5. PMA/510(K)#: THE PANEL PHOENIX NMIC/ID-311 IS AN ANTIMICROBIAL RESISTANCE PANEL THAT CONSISTS OF A COMBINATION OF THE FOLLOWING 510K NUMBERS: K032299, K061355, K061327, K031912, K023444, K063824, K033560, K063573, K041384, K060217, K052269, K190905, K032655, K062944, K060444, K173252, K033362, K062207, K063811, K163637, K151320, K063301, K031530, K060447, K032567, K060257, K023634, K123404, K020322, K132674, K173523, K063486, K022129, K023858, K071623, K031699, K060447, K024153, K060214, K132909, K042932 H.3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. H3 OTHER TEXT :
THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED AND/OR ADDITIONAL INFORMATION: B3: DATE OF EVENT: 28-OCT-2023. B5: DESCRIBE EVENT: IT WAS REPORTED WHEN USING THE BD PHOENIX¿ NID A PATIENT URINE ISOLATE (B)(6) WAS RESULTED AS POSITIVE FOR EXTENDED SPECTRUM BETA-LACTAMASE (ESBL). THE RESULT WAS CONFIRMED TO BE NEGATIVE BY KIRBY BAUER CULTURE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 4.. B6: RELEVANT TESTS/LABORATORY DATA: BACTERIAL CULTURE - KIRBY BAUER. D1: MEDICAL DEVICE BRAND NAME: BD PHOENIX¿ NID. D2A: COMMON DEVICE NAME: GRAM NEGATIVE IDENTIFICATION PANEL. D2B: MEDICAL DEVICE TYPE: LQM. D4: MEDICAL DEVICE CATALOG #: 448007. D4: MEDICAL DEVICE LOT #: 3202514. D.4: MEDICAL DEVICE EXPIRATION DATE: 11-JUL-2024. D.5: UNIQUE IDENTIFIER (UDI) # (B)(4). H.4. DEVICE MANUFACTURE DATE: 21-JUL-2023.
IT WAS REPORTED WHEN USING THE BD PHOENIX¿ NID A PATIENT URINE ISOLATE (420074512450) WAS RESULTED AS POSITIVE FOR EXTENDED SPECTRUM BETA-LACTAMASE (ESBL). THE RESULT WAS CONFIRMED TO BE NEGATIVE BY KIRBY BAUER CULTURE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 4.
REPORT 2 OF 4 IT WAS REPORTED THAT DURING USE OF THE BD PANEL PHOENIX NMIC-311, THERE WAS FALSE POSITIVE ESBL ON K. OXYTOCA. THERE WAS NO ADVERSE IMPACT TO PATIENT REPORTED.
IT WAS REPORTED WHEN USING THE BD PHOENIX¿ NID A PATIENT URINE ISOLATE (B)(6) WAS RESULTED AS POSITIVE FOR EXTENDED SPECTRUM BETA-LACTAMASE (ESBL). THE RESULT WAS CONFIRMED TO BE NEGATIVE BY KIRBY BAUER CULTURE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 4.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 374204 | BD PHOENIX¿ NID | GRAM NEGATIVE IDENTIFICATION PANEL | LQM | BECTON, DICKINSON & CO. (SPARKS) | 3202514 | 30382904480074 | |
| 708989 | BD PHOENIX¿ NID | GRAM NEGATIVE IDENTIFICATION PANEL | LQM | BECTON, DICKINSON & CO. (SPARKS) | 3202514 | 30382904480074 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |